Evidence map›Paper›PMID 42346415›Full record

ReviewJournal of xenobiotics2026

Analysis and Risks of Emerging Contaminants and Microplastics in Natural and Treated Waters and Human Health: A Critical Review.

Maryam Mallek, Damià Barceló

Abstract readReview
In one paragraph

Review in Journal of xenobiotics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maryam MallekLaboratory of Material Sciences and Environment, Faculty of Sciences, University of Sfax, Route de la Soukra Km 3.5, BP 1171, Sfax 3000, Tunisia.ORCID 0000-0003-3384-9185
Damià BarcelóChemistry and Physics Department, University of Almeria, Ctra Sacramento s/n, 04120 Almería, Spain.ORCID 0000-0002-8873-0491

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging contaminants (ECs) and microplastics (MPs) are increasingly detected in surface waters, wastewaters, and drinking water, often as complex mixtures, transformation products, and particle-associated burdens that challenge routine monitoring. This critical review examines current analytical strategies for the detection and characterization of both molecular and particulate emerging contaminants in aquatic systems, with particular emphasis on their relevance to environmental and human health risk assessment. For molecular ECs, targeted LC-MS/MS and GC-MS and GC-MS/MS approaches are evaluated alongside high-resolution mass spectrometry (HRMS)-based suspect and non-target screening, retrospective data mining, and transformation-product elucidation. For MPs, particle-resolved vibrational spectroscopy including µ-FTIR and µ-Raman is critically assessed in comparison with complementary thermal analysis methods, such as pyrolysis-GC-MS and thermal extraction-desorption GC-MS (TED-GC-MS). Particular attention is given to the influence of sampling design, matrix-adapted sample preparation, analytical confidence, and method-dependent size and polymer coverage on data quality and interstudy comparability. The review further highlights the risks of ECs in relation to exposure pathways, mixture effects, and the potential carrier role of MPs for ECs, additives, and microorganisms. Finally, key priorities are identified for next-generation monitoring frameworks, including harmonized workflows, transparent confidence reporting, and stronger integration of analytical evidence with fate, exposure, and risk assessment.

Indexed as

emerging contaminantshigh-resolution mass spectrometrymicroplasticsnon-target screeningrisk assessmentsuspect screeningwater monitoring

Identifiers

PMID42346415
PMCPMC13302567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.